CN Patent

CN120714024A — 抗pd-1抗体及其用途

Assigned to Incyte Corp · Expires 2025-09-30 · 1y expired

What this patent protects

本发明涉及抗PD‑1抗体及其用途，具体公开了用结合至PD‑1的抗体和抗体片段治疗癌症的方法。

USPTO Abstract

本发明涉及抗PD‑1抗体及其用途，具体公开了用结合至PD‑1的抗体和抗体片段治疗癌症的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN120714024A
Jurisdiction
CN
Classification
—
Expires
2025-09-30
Drug substance claim
No
Drug product claim
No
Assignee
Incyte Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.